Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Rohn

Showing results (31-40 of 75) with videos related to

Pageof 8
Sort By:
International Journal of Physiology, Pathophysiology and Pharmacology|April 23, 2010
Caspase cleavage of the amyloid precursor protein is prevented after overexpression of bcl-2 in a triple transgenic mouse model of Alzheimer's diseaseDebra K Kumasaka, Veronica Galvan, Elizabeth Head, et al.
Journal of Parkinson'S Disease and Alzheimer'S Disease|January 17, 2015
Is Apolipoprotein E4 an Important Risk Factor for Dementia in Persons with Down Syndrome?Troy T Rohn, Katie L McCarty, Julia E Love, et al.
International Journal of Clinical and Experimental Medicine|January 9, 2010
Caspase activation in transgenic mice with Alzheimer-like pathology: results from a pilot study utilizing the caspase inhibitor, Q-VD-OPhTroy T Rohn, Polina Kokoulina, Cody R Eaton, et al.
Drug News & Perspectives|April 5, 2003
Caspase Activation in the Alzheimer's Disease Brain: Tortuous and TorturousTroy T. Rohn, Robert A. Rissman, Elizabeth Head, et al.
The American Journal of Pathology|March 2, 2006
Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer's disease brainPeter E Mouser, Elizabeth Head, Kwang-Ho Ha, et al.
Biochemical Pharmacology|November 24, 1998
U-101033E (2,4-diaminopyrrolopyrimidine), a potent inhibitor of membrane lipid peroxidation as assessed by the production of 4-hydroxynonenal, malondialdehyde, and 4-hydroxynonenal--protein adductsT T Rohn, L K Nelson, G Waeg, et al.
Journal of Alzheimer'S Disease & Parkinsonism|August 10, 2018
The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Alzheimer's DiseaseTroy T Rohn, Nayoung Kim, Noail F Isho, et al.
Neuroreport|March 30, 2001
15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosisT T Rohn, S M Wong, C W Cotman, et al.
Proceedings of the Western Pharmacology Society|January 1, 1993
Stobadine protects ion pump ATPases from free radical inhibitionK A Clinch, F F Vincenzi, T T Rohn, et al.
Brain Research|August 21, 2012
Identification of an amino-terminal fragment of apolipoprotein E4 that localizes to neurofibrillary tangles of the Alzheimer's disease brainTroy T Rohn, Lindsey W Catlin, Kendra G Coonse, et al.
Pageof 8

Showing results (31-40 of 75) with videos related to

Sort By:
Pageof 8
International Journal of Physiology, Pathophysiology and Pharmacology|April 23, 2010
Caspase cleavage of the amyloid precursor protein is prevented after overexpression of bcl-2 in a triple transgenic mouse model of Alzheimer's diseaseDebra K Kumasaka, Veronica Galvan, Elizabeth Head, et al.
Journal of Parkinson'S Disease and Alzheimer'S Disease|January 17, 2015
Is Apolipoprotein E4 an Important Risk Factor for Dementia in Persons with Down Syndrome?Troy T Rohn, Katie L McCarty, Julia E Love, et al.
International Journal of Clinical and Experimental Medicine|January 9, 2010
Caspase activation in transgenic mice with Alzheimer-like pathology: results from a pilot study utilizing the caspase inhibitor, Q-VD-OPhTroy T Rohn, Polina Kokoulina, Cody R Eaton, et al.
Drug News & Perspectives|April 5, 2003
Caspase Activation in the Alzheimer's Disease Brain: Tortuous and TorturousTroy T. Rohn, Robert A. Rissman, Elizabeth Head, et al.
The American Journal of Pathology|March 2, 2006
Caspase-mediated cleavage of glial fibrillary acidic protein within degenerating astrocytes of the Alzheimer's disease brainPeter E Mouser, Elizabeth Head, Kwang-Ho Ha, et al.
Biochemical Pharmacology|November 24, 1998
U-101033E (2,4-diaminopyrrolopyrimidine), a potent inhibitor of membrane lipid peroxidation as assessed by the production of 4-hydroxynonenal, malondialdehyde, and 4-hydroxynonenal--protein adductsT T Rohn, L K Nelson, G Waeg, et al.
Journal of Alzheimer'S Disease & Parkinsonism|August 10, 2018
The Potential of CRISPR/Cas9 Gene Editing as a Treatment Strategy for Alzheimer's DiseaseTroy T Rohn, Nayoung Kim, Noail F Isho, et al.
Neuroreport|March 30, 2001
15-deoxy-delta12,14-prostaglandin J2, a specific ligand for peroxisome proliferator-activated receptor-gamma, induces neuronal apoptosisT T Rohn, S M Wong, C W Cotman, et al.
Proceedings of the Western Pharmacology Society|January 1, 1993
Stobadine protects ion pump ATPases from free radical inhibitionK A Clinch, F F Vincenzi, T T Rohn, et al.
Brain Research|August 21, 2012
Identification of an amino-terminal fragment of apolipoprotein E4 that localizes to neurofibrillary tangles of the Alzheimer's disease brainTroy T Rohn, Lindsey W Catlin, Kendra G Coonse, et al.
Pageof 8